Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Cancers
|
May 14, 2025
Differential Infiltration of T-Cell Populations in Tumor and Liver Tissues Predicts Recurrence-Free Survival in Surgically Resected Hepatocellular Carcinoma
Eun Ji Jang, Ho Joong Choi, Young Kyoung You, et al.
Gut and Liver
|
May 6, 2026
High Cardiometabolic Risk Burden Predicts Adverse Outcomes in Patients with MASLD-Related Hepatocellular Carcinoma
Yeonhong Do, Young Hyeon Ahn, Young Chang, et al.
Frontiers in Immunology
|
June 26, 2025
Peripheral blood inflammatory score using a cytokine multiplex assay predicts clinical outcomes in patients treated with atezolizumab-bevacizumab for unresectable HCC
Hee Sun Cho, Soon Kyu Lee, Ji Won Han, et al.
Frontiers in Immunology
|
December 25, 2024
Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab
Jaejun Lee, Jae-Sung Yoo, Ji Hoon Kim, et al.
Journal of Gastroenterology
|
July 21, 2025
The PNPLA3 I148M variant is associated with immune cell infiltration and advanced fibrosis in MASLD: a prospective genotype-phenotype study
Jaejun Lee, Jung Hoon Cha, Hee Sun Cho, et al.
Scientific Reports
|
May 21, 2026
Liver fibrosis burden and risk of incident arrhythmia in metabolic dysfunction-associated steatotic liver disease
Keungmo Yang, Seung Hyun Kim, Jaejun Lee, et al.
Diabetes & Metabolism Journal
|
June 10, 2026
Fibroblast- and Macrophage-Derived Thrombospondin-1 Orchestrates the Fibroinflammatory Niche in Metabolic Dysfunction-Associated Steatohepatitis-Induced Fibrosis
Sung Woo Cho, Jung Hoon Cha, Deok Wha Seo, et al.
Frontiers in Oncology
|
December 27, 2024
Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma
Ji Yeon Lee, Jaejun Lee, Suho Kim, et al.
Hepatology (Baltimore, Md.)
|
August 20, 2025
CX3CR1+ macrophages interact with HSCs to promote HCC through CD8+ T-cell suppression
Jong-Min Jeong, Sung Eun Choi, Young-Ri Shim, et al.
Hepatology (Baltimore, Md.)
|
May 1, 2021
Metabotropic Glutamate Receptor 5 in Natural Killer Cells Attenuates Liver Fibrosis by Exerting Cytotoxicity to Activated Stellate Cells
Won-Mook Choi, Tom Ryu, Jun-Hee Lee, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Cancers
|
May 14, 2025
Differential Infiltration of T-Cell Populations in Tumor and Liver Tissues Predicts Recurrence-Free Survival in Surgically Resected Hepatocellular Carcinoma
Eun Ji Jang, Ho Joong Choi, Young Kyoung You, et al.
Gut and Liver
|
May 6, 2026
High Cardiometabolic Risk Burden Predicts Adverse Outcomes in Patients with MASLD-Related Hepatocellular Carcinoma
Yeonhong Do, Young Hyeon Ahn, Young Chang, et al.
Frontiers in Immunology
|
June 26, 2025
Peripheral blood inflammatory score using a cytokine multiplex assay predicts clinical outcomes in patients treated with atezolizumab-bevacizumab for unresectable HCC
Hee Sun Cho, Soon Kyu Lee, Ji Won Han, et al.
Frontiers in Immunology
|
December 25, 2024
Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab
Jaejun Lee, Jae-Sung Yoo, Ji Hoon Kim, et al.
Journal of Gastroenterology
|
July 21, 2025
The PNPLA3 I148M variant is associated with immune cell infiltration and advanced fibrosis in MASLD: a prospective genotype-phenotype study
Jaejun Lee, Jung Hoon Cha, Hee Sun Cho, et al.
Scientific Reports
|
May 21, 2026
Liver fibrosis burden and risk of incident arrhythmia in metabolic dysfunction-associated steatotic liver disease
Keungmo Yang, Seung Hyun Kim, Jaejun Lee, et al.
Diabetes & Metabolism Journal
|
June 10, 2026
Fibroblast- and Macrophage-Derived Thrombospondin-1 Orchestrates the Fibroinflammatory Niche in Metabolic Dysfunction-Associated Steatohepatitis-Induced Fibrosis
Sung Woo Cho, Jung Hoon Cha, Deok Wha Seo, et al.
Frontiers in Oncology
|
December 27, 2024
Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma
Ji Yeon Lee, Jaejun Lee, Suho Kim, et al.
Hepatology (Baltimore, Md.)
|
August 20, 2025
CX3CR1+ macrophages interact with HSCs to promote HCC through CD8+ T-cell suppression
Jong-Min Jeong, Sung Eun Choi, Young-Ri Shim, et al.
Hepatology (Baltimore, Md.)
|
May 1, 2021
Metabotropic Glutamate Receptor 5 in Natural Killer Cells Attenuates Liver Fibrosis by Exerting Cytotoxicity to Activated Stellate Cells
Won-Mook Choi, Tom Ryu, Jun-Hee Lee, et al.
Page
of 6